HSP90AA1 and Burkitt lymphoma: Particularly, in the context of BL, our study is the first attempt to show that HSP90 inhibitors can enhance the cytotoxic effect of CIK cells via the Fas/FasL signaling pathway, which consequently activates caspase3/7-dependent apoptosis.